Effect of a Probiotic, Lactobacillus Gasseri BNR17, on Body Composition and Weight Management in Overweight Adults

Inclusion Criteria: * Written informed consent; * Aged between 25 and 65 years inclusive; * Body mass index between 25.0 to 29.9 Kg/m2, inclusive; * Waist-hip ratio of ≥0.91 for males and ≥0.81 for females; * Sedentary lifestyle, exercising ≤2 times/week; * Good general health, as determined by the investigator; * Willing to consume the investigational product daily for the duration of the study; * Outside the healthy parameters of visceral adipose tissue, defined as 762 cm3 for males and 256 cm3 for females. Exclusion Criteria: * Females who are pregnant, lactating or wish to become pregnant during the study; * Participant regularly takes probiotic supplements, or has within the 4-weeks prior to randomisation or plans to during the study; * Participant is hypersensitive to any of the components of the investigational product; * Participant is severely immuno-compromised (HIV positive, transplant patient, on antirejection medications, on a steroid for \>30 days, or has underwent chemotherapy or radiotherapy within the last year); * Participant has Type 1 or Type 2 Diabetes Mellitus; * Participant has a history of bariatric surgery; * Participant has taken anti-obesity medication or supplements in the 12-weeks prior to randomisation or plans to during the study; * Participant is actively or has recently (3 months prior to randomisation) participated in a weight loss program or weight change of 3 kg during the past 3 months; * Participant has a life-threatening illness; * Participant is on a glucose lowering medication, anti-psychotic drugs or any medication that the investigator determines could impact the results of the study; participant has commenced use, within 3-months of randomisation, anti-hypertensive drugs, anti-depressive drugs, statin or any other medication that the investigator determines could impact the results of the study; * Participant has a history of co-existing gastrointestinal, and/or gynecological, and/or urologic pathology (e.g. colon cancer, colitis, Crohn's Disease, Celiac, Endometriosis, prostate cancer) or lactose intolerance; * Participant has a recent history of drug and/or alcohol abuse at the time of enrolment; * Participant is currently, or planning to participate in another study during the study period; * Participant has a history of non-compliance; * Participant has taken antibiotics in the 12-weeks prior to randomisation.